Scarica l'app Stockscreener
22.99
1.71%
-0.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ENOV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$23.39
Aprire:
$23.68
Volume 24 ore:
977.87K
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.32B
Reddito:
$2.19B
Utile/perdita netta:
$-829.17M
Rapporto P/E:
-1.6133
EPS:
-14.25
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
-6.20%
1M Prestazione:
+5.60%
6M Prestazione:
-27.52%
1 anno Prestazione:
-35.80%
Intervallo 1D:
$22.78
$24.11
Intervallo di 1 settimana:
$22.62
$24.90
Portata 52W:
$21.00
$40.70
Enovis Corp Stock (ENOV) Company Profile
Nome
Enovis Corp
Settore
Industria
Telefono
(302) 252-9160
Indirizzo
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.99 | 1.32B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Iniziato | BTIG Research | Buy |
| 2024-10-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-06-13 | Iniziato | JP Morgan | Neutral |
| 2024-02-13 | Iniziato | Stephens | Overweight |
| 2024-01-22 | Iniziato | UBS | Buy |
| 2024-01-03 | Iniziato | William Blair | Outperform |
| 2023-12-15 | Reiterato | Needham | Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-06-26 | Iniziato | Needham | Buy |
| 2023-05-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-11 | Iniziato | Goldman | Buy |
| 2022-09-12 | Iniziato | Canaccord Genuity | Buy |
| 2022-09-12 | Iniziato | Evercore ISI | Outperform |
| 2022-06-28 | Iniziato | Argus | Hold |
| 2022-06-27 | Ripresa | Loop Capital | Buy |
| 2022-06-16 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Enovis Corp Borsa (ENOV) Ultime notizie
How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation - Yahoo Finance UK
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Top Enovis Insider Makes Bold Move With Fresh Stock Purchase - TipRanks
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV - Investing.com South Africa
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade - Stock Titan
ENOV SEC FilingsEnovis Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Barclays PLC Lowers Stake in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook UpdateHas The Bull Case Changed? - simplywall.st
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Enovis (ENOV) HR chief awarded 25,586 RSUs, 2,969 shares withheld - Stock Titan
Enovis (ENOV) exec Louis Vogt awarded 36,247 RSUs; 1,980 shares withheld for taxes - Stock Titan
Unveiling Q4 Financial Results: How Enovis (NYSE:ENOV) Compares With Other Specialty Medical Devices & Supplies Stocks - Bitget
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
A Look At Enovis (ENOV) Valuation After 2025 Earnings Losses And 2026 Revenue Guidance - simplywall.st
Enovis Outperforms Rennova Health in Key Financial Metrics - National Today
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings - AOL.com
Aug Macro: Can Enovis Corporation ride the EV waveStop Loss & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Enovis (ENOV) CFO logs 2,220-share tax withholding, holds 113,789 shares - Stock Titan
Enovis (ENOV) HR chief has 1,173 RSU shares withheld to cover taxes - Stock Titan
Zacks Research Upgrades Enovis (NYSE:ENOV) to Strong-Buy - MarketBeat
Enovis (ENOV) Q4 earnings beat estimates - MSN
Insider Buying: Enovis (NYSE:ENOV) Insider Buys 1,000 Shares of Stock - MarketBeat
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet - Finviz
Why Enovis (ENOV) Is Up 10.5% After 2025 Losses And 2026 Growth Guidance - simplywall.st
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com Nigeria
ENOV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enovis (NYSE:ENOV) Insider Purchases $25,500.00 in Stock - MarketBeat
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in market trade - Stock Titan
Enovis (ENOV) CFO records 720-share tax withholding transaction - Stock Titan
Enovis Corporation (ENOV): Investor Outlook On A Promising 75.8% Potential Upside - DirectorsTalk Interviews
Enovis Corp. Hits Day High with Strong 13.89% Intraday Surge - Markets Mojo
Enovis (ENOV) executive Louis Vogt has 889 shares withheld for taxes - Stock Titan
Enovis Outperforms Rennova Health in Financial Comparison - National Today
Enovis Reports Strong Q4 and Full-Year 2025 Results - National Today
Enovis Corporation $ENOV Shares Sold by Royce & Associates LP - MarketBeat
Vanguard Group Inc. Boosts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
A Look At Enovis (ENOV) Valuation After Earnings Beat And Higher 2026 Profit Guidance - simplywall.st
American Century Companies Inc. Sells 258,262 Shares of Enovis Corporation $ENOV - MarketBeat
AI Reliance Raises Operational, Regulatory, and Reputational Risks for Enovis Corporation - The Globe and Mail
Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth - simplywall.st
Enovis Corporation (NYSE:ENOV) Q4 2025 Earnings Call Transcript - Insider Monkey
Enovis Reports Strong 2025 Performance, Outlines 2026 Outlook - National Today
Enovis Balances Revenue Growth And New Devices With Goodwill Impairment - Yahoo Finance
Enovis Q4 Earnings Call Highlights - MarketBeat
Enovis Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:ENOV) 2026-02-27 - Seeking Alpha
Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating - marketscreener.com
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Needham Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $52 - 富途牛牛
Enovis (NYSE:ENOV) Posts Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Enovis Corp Azioni (ENOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):